• Sign Up

Features, Evaluation, and Treatment of Coronavirus

  Features, Evaluation, and Treatment of Coronavirus

Credits: 1.25   Post-Assessment Questions:  9

Release Date: 5 Oct 2020
Expiration Date: 4 Oct 2021
Last Reviewed: 4 Oct 2020
Estimated Time To Finish: 75 Minutes

Need Help?  If you have a system or content concerns, please contact support@statpearls.com, or call (727) 289-9796.

Activity Description

According to the World Health Organization (WHO), viral diseases continue to emerge and represent a serious issue to public health. In the last twenty years, several viral epidemics such as the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) in 2002-2003, and H1N1 influenza in 2009, have been recorded. Most recently, the Middle East Respiratory Syndrome coronavirus (MERS-CoV) was first identified in Saudi Arabia in 2012. An epidemic of cases with unexplained low respiratory infections was first detected in Wuhan, the largest metropolitan area in China's Hubei province, was first reported to the WHO Country Office in China, on 31 December 2019. Published literature can trace the beginning of symptomatic individuals back to the beginning of December 2019. As they were unable to identify the causative agent, these first cases were classified as "pneumonia of unknown etiology." The Chinese Center for Disease Control and Prevention (CDC) and local CDCs organized an intense outbreak investigation program. The etiology of this illness is now attributed to a novel virus belonging to the coronavirus (CoV) family, COVID-19. This activity describes the evaluation and treatment of COVID-19 and the role of the interprofessional team in managing patients with this condition.

Target Audience

This activity has been designed to meet the educational needs of physicians.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the etiology of coronavirus in patients.
  • Describe the findings expected in patients with coronavirus.
  • Summarize treatment options available for coronavirus.

Author(s) / Contributors Disclosure of Conflicts of Interest

Each author, editor, faculty and planning committee member have completed a disclosure form indicating that neither they nor their spouse/partner has a financial interest/arrangement or affiliation that could be perceived as a real or apparent conflict of interest related to the content of this activity.

COMMERCIAL SUPPORT: This activity has received NO commercial support.


Hover over the contributor names to see details and disclosures of any financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity.

Authors: Marco Cascella, Michael Rajnik, Arturo Cuomo, Scott Dulebohn
Editors: Raffaela Di Napoli
Editors-In-Chief: Cynthia OsterWanda Wright
Chief Medical Reviewer: Michael Rajnik
Nurse Planner/Reviewer/Editor: Lisa Haddad
Pharmacy Planner/Reviewer/Editor: Mark Pellegrini
Physician Planner/Reviewer/Editor: Scott Dulebohn

Continuing Education Accreditation Information

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Quillen College of Medicine, East Tennessee State University, and StatPearls, LLC. The Quillen College of Medicine, East Tennessee State University is accredited by the ACCME to provide continuing medical education for physicians.

Quillen College of Medicine, East Tennessee State University designates this activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.


Cancellation Policy: Cancellations must be received in writing and a money-back guarantee is provided if not completely satisfied.

  • StatPearls and ETSU reserve the right to cancel any course due to unforeseen circumstances. StatPearls and ETSU will not be responsible for other expenses incurred by the participant in the unlikely event that the program is canceled.

Equal Opportunity

  • StatPearls and ETSU are Equal Opportunity / Affirmative Action / Equal Access Institutions. 

Medium or Media Used:

  • Computer Requirements:  Internet Access
  • E-mail Address

Instructions for Credit

  1. Register for the activity and create a StatPearls login.     
  2. Review the required accreditation information:  Target audience, learning objectives, and disclosure information.
  3. Complete the entire self-study activity.
  4. Complete the post-test assessments.
  5. Successfully pass the post-test with a minimum score of 100%.
  6. Complete the evaluation form.
  7. Obtain a certificate.

StatPearls and ETSU adhere to ACCME Standards regarding commercial support of continuing medical education. It is the policy of StatPearls and ETSU that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that authors and editors will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made prior to starting the activity.

The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

Media Usage Rights

The contributors and editors of StatPearls have attested that all associated media (images and video) have been legally cleared for use with this activity.  All copyrights are reserved.

  • Name: 'Covid Replication.png' Attribution: Contributed by Rohan Bir Singh, MD
  • Name: 'Clinical Presentations of Patients with Covid-19.png' Attribution: Contributed by Rohan Bir Singh, MD; Made with Biorender.com
  • Name: 'SARS-CoV 2 Structure.png' Attribution: Contributed by Rohan Bir Singh, MD; Made with Biorender.com
  • Name: 'Transmission Cycle of SARS CoV 2.png' Attribution: Contributed by Rohan Bir Singh, MD; Made with Biorender.com
  • Name: 'Single Stranded RNA SARS.jpg' Attribution: Contributed by Rohan Bir Singh, MD; Made with Biorender.com

Average Rating: 4.62

5 Star
4 Star
3 Star
2 Star
1 Star

  • by Copy E.| Rating | Date : 10/6/2020
  • by Fred F.| Rating | Date : 10/6/2020
  • by Carina R.| Rating | Date : 10/6/2020
    Comment: none
  • by Syed A.| Rating | Date : 10/14/2020
  • by Jeffrey M.| Rating | Date : 10/13/2020
    Comment: x
  • by Hamed B.| Rating | Date : 10/13/2020
    Comment: too long questionauer.
  • by Abhishek S.| Rating | Date : 10/14/2020
  • by Neelima T.| Rating | Date : 10/15/2020
  • by Margaret H.| Rating | Date : 10/15/2020
    Comment: Excellent article, hope to use this for future CME.
  • by Bahgat Thabet W.| Rating | Date : 10/14/2020
  • by Bahgat Thabet W.| Rating | Date : 10/14/2020
  • by Erich W.| Rating | Date : 10/16/2020
  • by Daniela A.| Rating | Date : 10/20/2020